CTRI/2023/09/057287已完成Unknown
A Randomized, Double Blind, Two Arm, Parallel, Placebo-Controlled, Safety and Efficacy Study of Anti-Ageing and Skin Brightening Gel. - NI
Green Mountain Biotech Limited0 个研究点目标入组 44 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Age: 35 to 55 years (both inclusive) at the time of consent.
- •2) Sex: Healthy and non-pregnant/non-lactating females.
- •3) Subjects who are generally in good health as determined by/form recent medical history.
- •4) Female of child bearing capacity must have a self-reported negative pregnancy test.
- •5) Subjects having mild to moderate crows’ feet wrinkles.
- •6) Subjects having a score of at least mild skin aging ? based on PGA at screening visit.
- •7) Subjects having a score of at least mild skin pigmentation ? based on Skin Pigmentation Score at screening visit.
- •8) Subjects having Glogau Skin Age II or III as assessed by the Dermatologist/ Dermatologist Trained Evaluator.
- •9) Subjects who are willing to forgo cosmetic procedures for the duration of the study.
- •10) Subjects who are able to follow their normal skin care routines and to refrain from introducing any new skin care products during the study.
- •11) Subjects who are willing not to introduce any new soaps, cleansers, lotions, creams, or any other face products etc. for the duration of the study.
- •12) Subjects who are willing to give written informed consent and are willing to follow the study procedure.
- •13) Subjects who commit not to use medicated/ prescription anti-ageing and skin brightening products or any other anti-ageing and skin brightening products other than the test products for the entire duration of the study.
- •14) Subjects who are willing to use test products throughout the study period.
排除标准
- •1) Subjects having a history of allergy or sensitivity to the test treatments ingredients.
- •2) Subjects who have pre-existing or dormant dermatologic conditions (e.g., psoriasis rashes, eczema, seborrheic dermatitis, acne or any other) that could interfere with the outcome of the study as determined by the Investigator.
- •3) Subjects who have used any systemic therapy with chronic antibiotic therapy, retinoids, and/or oral steroids during the 4 weeks prior to the start or anticipates having to use at any point during the study.
- •4) Subjects who have applied any topical retinoids within 2 weeks of the screening visit or anticipates having to use at any point during the study.
- •5) Subjects not willing to avoid unprotected sun or other UV radiation exposure during the study period.
- •6) Subjects having a history of alcohol or drug addiction.
- •7) Subjects who have used any systemic therapy with chronic antibiotic therapy, retinoids, and/or oral steroids during the 4 weeks prior to the start or anticipates having to use at any point during the study.
- •8) Subjects who have applied any topical retinoids or glutathione within 2 weeks of the screening visit or anticipates having to use at any point during the study.
- •9) Subjects not willing to avoid unprotected sun or other UV radiation exposure during the study period.
- •10) Subjects who are currently pregnant/breastfeeding or planning to become pregnant during the study period.
研究者
相似试验
尚未招募
1 期
Comparative PK, PD and Immunogenicity Study of ADL-018 Lyophilized Powder With Xolair XOLAIR Lyophilized Powder.CTRI/2022/08/045092Kashiv BioSciences LLC
进行中（未招募）
不适用
To know the effect of i-CHARGE drink in improvement of physical energy and mental alertnessCTRI/2019/05/019212Indus Viva Health sciences Pvt Ltd
招募中
3 期
Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients with Type II Diabetestype 2 diabetes.Type 2 diabetes mellitusIRCT20150303021315N15CinnaGen Company300
尚未招募
2 期
To study the effect of Turmeric capsules in healthy adult female participants.CTRI/2024/06/068637utriventia Limited Unit
已完成
2 期
Clinical study of JPT-25 capsules in people with smoking habitsCTRI/2017/06/008787Gurseet Singh103